Maureen Deehan

Director/Board Member at ADOCIA

Consumer Services

Health Technology

Commercial Services

Profile

Maureen Deehan is currently Chief Executive Officer at Vivtex Corp.
since 2023 and Independent Director at Adocia SA starting in 2026.
Formerly, Dr. Deehan was Head of Corporate Development & Strategy at Nordic Nanovector ASA. Education includes an undergraduate degree from the University of Strathclyde and a doctorate from the University of Glasgow School of Medicine.

Maureen Deehan active positions

Companies	Position	Start
ADOCIA	Director/Board Member	2026-08-17
Vivtex Corp. Vivtex Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company that focuses on Gastrointestinal related diseases using oral oligonucleotide therapeutics	Chief Executive Officer	2023-02-20

All active positions of Maureen Deehan

Former positions of Maureen Deehan

Companies	Position	End
THOR MEDICAL	Corporate Officer/Principal	-

See the detail of Maureen Deehan's experience

Training of Maureen Deehan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Maureen Deehan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Strathclyde University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adocia SA Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases	Health Technology
Nordic Nanovector ASA Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics	Health Technology
University of Glasgow School of Medicine University of Glasgow School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vivtex Corp. Vivtex Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company that focuses on Gastrointestinal related diseases using oral oligonucleotide therapeutics	Commercial Services